Unfortunately, most mass media coverage of clinical trials has been negative and/or unbalanced, focusing largely on risks, human error, and questionable...
Unfortunately, most mass media coverage of clinical trials has been negative and/or unbalanced, focusing largely on risks, human error, and questionable motives.
The hesitancy to change is understandable given the potential impact on an organization. Are decentralized and hybrid trials right for your organization?
The future success of the life science industry in bringing new products to market rests on the ability of sponsors and CROs to work together successfully,...
The future success of the life science industry in bringing new products to market rests on the ability of sponsors and CROs to work together successfully, providing both parties a compelling incentive to strengthen their partnership with the help of the right structure, tools, and strategies.
The future success of the life science industry in bringing new products to market rests on the ability of sponsors and CROs to work together successfully, providing both parties a...
Globalization is adding to the complexity of running clinical trials and the pursuit of global trials is increasing. Globalization has an obvious impact on...
Globalization is adding to the complexity of running clinical trials and the pursuit of global trials is increasing. Globalization has an obvious impact on organizational structure of clinical operations teams, but what do the industry metrics have to say about cycle time performance of multi-country vs. single country studies? And economies of scale in clinical trials?
Globalization is adding to the complexity of running clinical trials and the pursuit of global trials is increasing. Globalization has an obvious impact on organizational structure of clinical...
As the industry evolves and data types, structures, and volume continue to increase, technology must also evolve.
As medical practitioners increasingly seek to provide proactive management for their patients health, new digitally enabled therapies are being developed that...
As medical practitioners increasingly seek to provide proactive management for their patients health, new digitally enabled therapies are being developed that consider disease progression and early preventative measures.
As medical practitioners increasingly seek to provide proactive management for their patients health, new digitally enabled therapies are being developed that consider disease progression and early...
The clinical trials sector has done a good job tracking costs associated with study execution, but costs linked to study startup are conspicuously absent.
Those of us in global health research and development must have courage to better what we do, so we can get life-saving products to market faster and in a less...
Those of us in global health research and development must have courage to better what we do, so we can get life-saving products to market faster and in a less costly fashion.
Contemporariness is particularity a problem for multi-country studies spanning numerous regulatory agencies. The key challenges arise from not having clearly...
Contemporariness is particularity a problem for multi-country studies spanning numerous regulatory agencies. The key challenges arise from not having clearly defined contemporariness in operational SOPs – this has resulted in audit findings.
Contemporariness is particularity a problem for multi-country studies spanning numerous regulatory agencies. The key challenges arise from not having clearly defined contemporariness in operational...
